IC-8 Apthera IOL

· Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IC-8 Apthera IOL, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: IC-8 Apthera IOL New Enrollment Post Approval Study